Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.
Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results